TenderTiger

Private Sector | Not Classified - india | PID: 196297
Gland Pharma has drawn up a capital expenditure plan of Rs 800 crore for FY23. This includes Rs 300 crore towards a new biotech vaccine facility

The pharma company expects to supply the Russian Sputnik vaccines made in India by the end of 2021

The company is expanding capacities with new lines and setting up a new R&D centre at the Pashamylaram facility in Hyderabad, Telangana. To scale up the backward integration, it is expanding its API capacity at the Vizag facility by adding a new block

| Updated on: 09 - Sep - 2021
Search Tenders By Product: Vaccines Project
To view this paid Project you can either "Buy this Project" or subscribe our annual Project Alert Service and get access to all similar Projects. If you are registered member, please fill in the subscription form below . If not, please Register first.
Step 1 - Select a plan
Select Plan Unit Rate Subscription Validity
Rs. 29500 /-
Step 2 - If registered user, please fill below form
(*) Mandatory fields
Email Id *
States Interested In
Projects Interested In
Select Payment Type
Verification Code *
Note : As Goods and Services Tax is set to be implemented from 1st July 2017. The transition provisions under GST law applies to all services provided by e-Procurement Technologies Limited to its clients on or after 1st July 2017 and GST tax rate and other taxes are applicable as extra for all services provided.